NCT00875459View on ClinicalTrials.gov

An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 1 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Diabetes Mellitus
Interventions
DRUG

VIAject™

Subcutaneous injection 25 IU/mL

Sponsors

Lead Sponsor

Biodel
All Listed Sponsors
lead

Biodel

INDUSTRY

NCT00875459 - An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter